dr well semaglutide Weight loss journeys with DNM What Makes Semaglutide Shine as

Originally the drug was designed for patients with diabetes, since it helps to manage blood sugar control

The New York Times reported that in one clinical trial, 63 percent of patients taking Wegovy showed clearance of fat and inflammation in the liver without worsening of scarring, compared to 34 percent in the placebo group

Tirzepatide (Mounjaro) has also been shown to significantly reduce the severity of sleep apnoea, mostly because weight loss puts less pressure on the airways

This recommendation is based on evidence that GLP-1 agonists (or another drug class called SGLT2 inhibitors) improve cardiovascular outcomes as well as other outcomes such as kidney disease, in patients who have established heart or kidney disease

Research published in the New England Journal of Medicine (SUSTAIN trials) demonstrated that semaglutide reduced body weight by approximately 12-15% over one year